Medical devices, healthcare technology and the business of care
510(k) clearance · K254199

PicoreMax (PicoreMax)

BLUECORE COMPANY Co., Ltd. · Decision date Sep 24, 2026

MEDTECHLEDGER EXPLANATIONK254199

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision for PicoreMax (PicoreMax) on 2026-09-24, under 510(k) number K254199. The applicant is BLUECORE COMPANY Co., Ltd. of Yangsan, Republic of Korea. The device falls under regulation 878.4810, classification name Powered Laser Surgical Instrument, product code GEX, with General & Plastic Surgery as the regulation medical specialty and review panel. The submission was a traditional 510(k) received 12/29/2025, not reviewed by a third party, not a combination product, and without an authorized predetermined change control plan.

SESE denotes clearance of this premarket notification, not premarket approval of a PMA or an original approval. The record describes the subject device at the category level only; the specific components, energy parameters, indications for use, and any comparative basis for the equivalence finding are not stated in the available material and remain unknown here. No clinical or performance conclusions are drawn.

The public page was last updated 11/09/2026. Applicant contact and correspondent contact are both listed as Kwon Bu Gyeong at the same Yangsan address.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General, Plastic Surgery
Decision date
Sep 24, 2026
FDA decision documents: 510(k) Premarket Notification - FDA

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K254199
Regulatory pathway
510(k) premarket notification
Product code
GEX
Decision code
SESE
Decision date
Sep 24, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Powered Laser Surgical Instrument.

Product code
GEX
FDA device class
2

FDA decision timeline

  1. K254199 received

    Application receipt date recorded by FDA.

  2. K254199 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code GEX

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

BLUECORE COMPANY Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Yangsan

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records